Cargando…
Methods matter – Tailoring SARS-CoV-2 antibody targets to vaccination status
Individuals who have been vaccinated for COVID19 should have IgG antibody in response to the specific antigen that is the target in the vaccine development. There are several options for targeted COVID19 antigen, but most manufacturers have focused on the spike protein. Using our understanding of th...
Autores principales: | Rapp, Alexandra R., Ogunbileje, John O., Djouodo-Nemzou, Diane, Okorodudu, Anthony O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8052504/ https://www.ncbi.nlm.nih.gov/pubmed/33872607 http://dx.doi.org/10.1016/j.cca.2021.04.009 |
Ejemplares similares
-
An issue of trust—vaccinating Black patients against COVID-19
por: Okorodudu, Dale O, et al.
Publicado: (2021) -
Outliers Matter—Correlation between S1 IgG SARS-CoV-2 Antibodies and Neutralizing SARS-CoV-2 Antibodies
por: Hocher, Berthold, et al.
Publicado: (2022) -
SARS-CoV-2 Vaccines: Status Report
por: Amanat, Fatima, et al.
Publicado: (2020) -
Antibody responses after SARS-CoV-2 vaccination in patients with lymphoma
por: Lim, Sean H, et al.
Publicado: (2021) -
CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)